$NVST

Envista Holdings Corp (NVST): Results of Operations and Financial Condition

Envista Holdings Corp (NVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nvst-ex991x7326xworkingfil.htm EX-99.1 Document Exhibit 99.1 Envista Reports Second Quarter 2026 Results BREA, Calif., August 5, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026. “We built on our

Original reporting
Published Aug 5, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NVST
Bullish
high confidence
Mentioned
$NVST
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NVSTBullishHigh
01

Why it matters

The key new tradable information is the combination of Q2 operating performance (including margin expansion and free cash flow) and the explicit increase to FY 2026 guidance ranges.

02

Market read

A guidance raise tied to margin expansion and cash flow is a direct input to FY valuation models and near-term positioning.

03

What to watch

The release emphasizes adjusted metrics and core sales; traders should scrutinize GAAP-to-adjusted reconciliation and whether free cash flow conversion remains near 100% through the second half.

Relevance 7/10Novelty 9/10Timing: after-hours filing on Aug 5, 2026, ahead of the investor call at 2:00 PM PT

Background

This is an SEC Form 8-K (Item 2.02) with Envista’s Q2 2026 results and updated full-year 2026 outlook.

Company-level read

Ticker impact

$NVSTBullishHigh confidence
Context

Envista reported Q2 results and raised full-year 2026 guidance for core sales growth, adjusted EBITDA, and adjusted EPS.

Expected impact

Likely positive bias for NVST as traders reprice FY 2026 growth and profitability expectations; follow-through depends on how the raised ranges compare with Street expectations.

Evidence & confidence

The filing discloses specific Q2 performance (sales, EPS, EBITDA margin, free cash flow) and a concrete guidance increase with quantified ranges, which is actionable for earnings-model updates.

Market effects

Dental products and services peers may see read-across on demand durability and margin trajectory if NVST’s guidance raise is viewed as sector-positive.

Limited direct regional spillover stated; growth is described across major geographies.

Global dental market sentiment could improve modestly if margin expansion and cash conversion are interpreted as resilient worldwide.

Counterpoint

Guidance raises may already be partially anticipated; if the raised ranges still imply deceleration or rely on non-GAAP adjustments, the stock reaction could fade.

Key entities

  • Envista Holdings Corporation

    Reported Q2 2026 results and raised FY 2026 guidance for core sales growth, adjusted EBITDA, and adjusted EPS.

  • Paul Keel

    CEO quoted on performance and the rationale for raising full-year outlook.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.